Aldeyra Therapeutics, Inc. Annual Return On Equity in % from 2014 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Aldeyra Therapeutics, Inc. annual/quarterly Return On Equity history and growth rate from 2014 to 2023.
  • Aldeyra Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2023 was -33.8 %.
  • Aldeyra Therapeutics, Inc. annual Return On Equity for 2023 was -29.5 %, a 19.5% increase from 2022.
  • Aldeyra Therapeutics, Inc. annual Return On Equity for 2022 was -36.6 %, a 24.3% decline from 2021.
  • Aldeyra Therapeutics, Inc. annual Return On Equity for 2021 was -29.4 %, a 55.9% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.